Malignant Tourette syndrome

Movement Disorders

Volumn 22, Issue 12, 2007, Pages 1743-1750

  Cheung, Min Yuen Cynthia ^a   Shahed, Joohi ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Malignant; Self injurious behavior; Tics; Tourette syndrome

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZATROPINE; BOTULINUM TOXIN; CARBAMAZEPINE; CLOMIPRAMINE; CLONAZEPAM; CLONIDINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUOXETINE; FLUPHENAZINE; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; OLANZAPINE; PAROXETINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SERTRALINE; TETRABENAZINE; TIOTIXENE; VALPROIC ACID; VENLAFAXINE;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; AUTOMUTILATION; COMORBIDITY; COMPLEX PHONIC; CONTROLLED STUDY; COPROLALIA; COPROPRAXIA; DATA ANALYSIS; EMERGENCY WARD; FEMALE; GILLES DE LA TOURETTE SYNDROME; HOSPITALIZATION; HUMAN; MALE; MEDICAL RECORD; MENTAL DISEASE; MOOD DISORDER; MOTOR DYSFUNCTION; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHOOL CHILD; SUICIDAL IDEATION; TEMPERAMENT; TIC; TREATMENT RESPONSE; VIOLENCE;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MALINGERING; MENTAL DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; RETROSPECTIVE STUDIES; TOURETTE SYNDROME;

EID: 34848914308     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21599     Document Type: Article

References (46)

1. Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000;123:425-462.
2. Jankovic J. Tourette's syndrome. N Engl J Med 2001;345:1184-1192.
3. Bloch MH, Peterson BS, Scahill L, et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006;160:65-69.
4. Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette's syndrome: the first two decades. Pediatrics 1998;102: 14-19.
5. Robertson MM, Trimble MR, Lees AJ. Self-injurious behavior and the Gilles de la Tourette syndrome: a clinical study and review of the literature. Psychol Med 1989;19:611-625.
6. Krauss JK, Jankovic J. Severe motor tics causing cervical myelopathy in Tourette's syndrome. Mov Disord 1996;11:563-566.
7. Wong AS, Massicotte EM, Fehlings MG. Surgical treatment of cervical myeloradiculopathy associated with movement disorders: indications, technique, and clinical outcome. J Spinal Disord Tech 2005;18:107-114.
8. Dobbs M, Berger JR. Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology 2003;60:1862-1863.
9. Muroi A, Matsumura A, Asakawa H, Enomoto T, Iwasaki N, Nose T. Myelopathy caused by tics in an adolescent, associated with T2 signal intensity changes of the spinal cord. Childs Nerv Syst 2002;18:191-194.
10. Adler CH, Zimmerman RS, Lyons MK, Simeone F, Brin MF. Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease. Mov Disord 1996;11:79-81.
11. Shimoyama T, Horie N, Kato T, Nasu D, Kaneko T. Tourette's syndrome with rapid deterioration by self-mutilation of the upper lip. J Clin Pediatr Dent 2003;27:177-180.
12. Jankovic J, Sekula S. Dermatologic manifestations of Tourette syndrome and obsessive-compulsive disorder. Arch Dermatol 1998;134:113-114.
13. Hood KK, Baptista-Neto L, Beasley PJ, Lobis R, Pradova I. Case study: severe self-injurious behavior in comorbid Tourette's Disorder and OCD. J Am Acad Child Adolesc Psychiatry 2004;43: 1298-1303.
14. Eisenhouer GLL, Woody RC. Self-mutilation and Tourette's disorder. J Child Neurol 1987;2:265-267.
15. Lim S, Rezai KA, Abrams GW, Eliot D. Self-induced, bilateral retinal detachment in Tourette syndrome. Arch Ophthalmol 2004; 122:930-931.
16. Gaillard MC, Wolfensberger TJ. Self-mutilation with crystalline lens dislocation in Gilles de la Tourette disease treated with retropupillary "iris claw" lens. Klin Monatsbl Augenheilkd 2004;221: 435-437.
17. Fusco C, Bertani G, Caricati G, Giustina ED. Stress fracture of the peroneal bone secondary to a complex tic. Brain Dev 2005;28:52-54.
18. Robertson M, Doran M, Trimble M, Lees AJ. The treatment of Gilles de la Tourette syndrome by limbic leucotomy. J Neurol Neurosurg Psychiatry 1990;53:691-694.
19. Price BH, Baral I, Cosgrove GR, et al. Improvement in severe self-mutilation following limbic leucotomy: a series of 5 consecutive cases. J Clin Psychiatry 2001;62:925-932.
20. The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol 1993;50:1013-1016.
21. Jankovic J, Kwak C, Frankoff R. Tourette syndrome and the law. J Neuropsychiatry Clin Neurosci 2006;18:86-95.
22. Robertson MM, Eapen V, van de Wetering BJ. Suicide in Gilles de la Tourette's syndrome: report of two cases. J Clin Psychiatry 1995;56:378.
23. Mathews CA, Jang KL, Herrera LD, et al. Tic symptom profiles in subjects with Tourette syndrome from two genetically isolated populations. Biol Psychiatry 2007;61:292-300.
24. Bloch MH, Sukhodolsky DG, Leckman JF, Schultz RT. Fine-motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome. J Child Psychol Psychiatry 2006;47:551-559.
25. Zhu Y, Leung KM, Liu PZ, Zhou M, Su LY. Comorbid behavioural problems in Tourette's syndrome are positively correlated with the severity of tic symptoms. Aust N Z J Psychiatry 2006; 40:67-73.
26. Bloch MH, Leckman JF, Zhu H, Peterson BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005;65:1253-1258.
27. Hoekstra PJ, Steenhuis MP, Troost PW, Korf J, Kallenberg CG, Minderaa RB. Relative contribution of attention-deficit hyperactivity disorder, obsessive-compulsive disorder, and tic severity to social and behavioral problems in tic disorders. J Dev Behav Pediatr 2004;25:272-279.
28. Sukhodolsky DG, Scahill L, Zhang H, et al. Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment. J Am Acad Child Adolesc Psychiatry 2003;42:98-105.
29. Stephens RJ, Sandor P. Aggressive behaviour in children with Tourette syndrome and comorbid attention-deficit hyperactivity disorder and obsessive-compulsive disorder. Can J Psychiatry 1999;44:1036-1042.
30. Mathews CA, Waller J, Glidden D, et al. Self-injurious behavior in Tourette syndrome: correlates with impulsivity and impulse control. J Neurol Neruosurg Psychiatry 2004;75:1149-1155.
31. Freeman RD, Fast DK, Burd L, et al. An international perspective on Tourette syndrome: selected findings from 3500 individuals from 22 countries. Dev Med Child Neurol 2000;42:436-447.
32. Cath DC, Spinhovern P, Hoogduin CAL, et al. Repetitive behaviors in Tourette' s syndrome and OCD with and without tics: what are the differences? Psychiatry Res 2001;101:171-85.
33. Lichter DG, Dmochowski J, Jackson LA, Trinidad KS. Influence of family history on clinical expression of Tourette's syndrome. Neurology 1999;52:308-316.
34. Como PG, LaMarsh J, O'Brien KA. Obsessive-compulsive disorder in Tourette's syndrome. Adv Neurol 2005;96:249-261.
35. Diniz JB, Rosario-Campos MC, Hounie AG, et al. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder. J Psychiatr Res 2006;40:487-493
36. Kwak CH, Dat Vuong KD, Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 2003;18:1530-1533.
37. Coffey BJ, Biederman J, Geller DA, et al. Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 2000; 39:556-561.
38. Robertson MM. Mood disorders and Gilles de la Tourette's syndrome: an update on prevalence, etiology, comorbidity, clinical associations, and implications. Psychosom Res 2006;61:349-358.
39. Apter A, Horesh N, Gothelf D, et al. Depression and suicidal behavior in adolescent inpatients with obsessive compulsive disorder. J Affect Disord 2003;75:181-189.
40. Silay YS, Jankovic J. Emerging drugs in Tourette syndrome. Expert Opin Emerg Drugs 2005;10:365-380.
41. Kenney C, Jankovic J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurother 2006;6:7-17.
42. Miguel EC, Shavitt RG, Ferrao YA, Brotto SA, Diniz JB. How to treat OCD in patients with Tourette syndrome. J Psychosom Res 2003;55:49-57.
43. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord 1994;9:347-349.
44. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000;57:1190-1193.
45. Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics: a randomize double-blind controlled clinical trial. Neurology 2001;56:605-610.
46. Shahed J, Poysky J, Kenney C, Simpson R, Jankovic J. GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric co-morbidities. Neurology 2007;68:159-160.